Meletios-Athanasios Dimopoulos

263PUBLICATIONS
507CO-AUTHORS
Major global burdens of diseaseMedical infection agents (incl. prions)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersNuclear physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (263)

|Oct 22, 2026
Outcomes of Patients With AL Amyloidosis and End-Stage Renal Disease After Initiation of Therapy.

|Aug 24, 2026
Myeloma Elderly Prognostic Score (MEPS): A Proposed Prognostic Score Integrating Age, Renal Function, Performance Status, and Ultra-High-Risk Cytogenetics.

|Aug 07, 2026
Validation of the new IMS/IMWG consensus genomic staging (CGS) of high-risk multiple myeloma (HRMM) in a contemporary cohort of 1209 patients.

|Jul 28, 2026
Signals in Peripheral Blood: Tracking Redox Status and DNA Damage Response During the Progression of Multiple Myeloma.

|Jul 22, 2026
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.

|May 04, 2026
Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3'U-tRFSerTGA leads to poor disease prognosis.

Pageof 44

Frequent Collaborators

118 joint publications

Evangelos Terpos

103 joint publications

Kastritis Efstathios

86 joint publications

Ioannis Ntanasis-Stathopoulos

60 joint publications

Maria Gavriatopoulou